Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 11 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Operating activities      
Net loss $ (27,017) $ (169,661) $ (30,406)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities      
Depreciation and amortization 10,112 24,458 15,431
Stock-based compensation 40,041 111,645 87,055
Amortization of premium on investments 237 1,911 2,833
Excess tax benefit from stock-based awards 0 0 (348)
Amortization of debt discount 0 1,084 0
Other operating activities 220 2,134 1,366
Changes in assets and liabilities      
Accounts receivable (60,613) (55,904) (55,478)
Prepaid expenses and other assets (7,891) (18,918) (9,219)
Accounts payable, accrued and other current liabilities 11,745 18,080 4,830
Accrued royalties 13,027 23,736 7,608
Accrued compensation (3,393) 7,378 13,736
Other long-term liabilities 5,607 6,005 7,690
Deferred revenue 13,384 4,946 (28,238)
Reimbursement of cost of leasehold improvements 1,555 1,024 4,169
Net cash provided by (used in) operating activities (2,986) (42,082) 21,029
Investing activities      
Purchases of property and equipment (21,180) (32,074) (30,039)
Purchases of patents (8,000) 0 0
Purchases of investments (224,549) (140,980) (340,679)
Proceeds from maturities of investments 42,210 228,998 258,518
Proceeds from sale of investments 0 111,356 0
Payments related to acquisitions, net of cash acquired (400) (269,566) 0
Net cash used in investing activities (211,919) (102,266) (112,200)
Financing activities      
Proceeds from issuance of convertible notes 0 345,000 0
Payments for purchase of capped call 0 (43,160) 0
Payment of debt issuance costs (450) (8,909) 0
Borrowings under debt arrangements 10,000 0 0
Repayments of debt (10,000) 0 0
Proceeds from follow-on offering, net of issuance costs 378,654 0 0
Proceeds from exercise of stock options 17,273 5,192 16,894
Tax payments from net share settlements of restricted stock units (480) (2,540) (2,019)
Excess tax benefit from stock-based awards 0 0 348
Proceeds from employee stock purchase plan 0 7,552 6,438
Net cash provided by financing activities 394,997 303,135 21,661
Effect of exchange rate changes on cash and cash equivalents (62) (77) (288)
Net increase (decrease) in cash and cash equivalents 180,030 158,710 (69,798)
Cash and cash equivalents at beginning of period 65,725 175,957 245,755
Cash and cash equivalents at end of period 245,755 334,667 175,957
Supplemental disclosures of cash flow information      
Cash paid during the period for income taxes 26 389 164
Cash paid during the period for interest 18 351 314
Purchases of property and equipment recorded in accounts payable and accrued liabilities 7,910 5,890 751
Fair value of shares issued related to the acquisition of a business $ 0 $ 146,855 $ 0